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Microreview
Molecular weaponry: diverse effectors delivered by the
Type VI secretion system
Juliana Alcoforado Diniz, Yi-Chia Liu and
Sarah J. Coulthurst*
Division of Molecular Microbiology, School of Life
Sciences, University of Dundee, Dundee DD1 5EH, UK.
Summary
The Type VI secretion system is a widespread
bacterial nanomachine, used to deliver toxins
directly into eukaryotic or prokaryotic target cells.
These secreted toxins, or effectors, act on diverse
cellular targets, and their action provides the
attacking bacterial cell with a significant fitness
advantage, either against rival bacteria or eukary-
otic host organisms. In this review, we discuss the
delivery of diverse effectors by the Type VI
secretion system, the modes of action of the so-
called ‘anti-bacterial’ and ‘anti-eukaryotic’ effec-
tors, the mechanism of self-resistance against
anti-bacterial effectors and the evolutionary impli-
cations of horizontal transfer of Type VI secretion
system-associated toxins. Whilst it is likely that
many more effectors remain to be identified, it is
already clear that toxins delivered by this secretion
system represent efficient weapons against both
bacteria and eukaryotes.
Introduction
Bacteria utilize protein secretion systems to deliver
specific proteins to the extracellular environment or
directly into target cells. Protein secretion systems, and
the proteins they translocate, play key roles in the
interactions of bacterial cells with host organisms,
competitor bacteria and the abiotic environment. The
Type VI secretion system (T6SS) is widespread in Gram-
negative bacteria and targets both eukaryotic and
prokaryotic cells, in a contact-dependent manner. The
T6SS nanomachine is composed of 13 conserved
components forming the core machinery (TssA–M),
together with variable accessory proteins. Our current
model of the structure and mode of action of the T6SS,
which exhibits striking parallels with the cell puncturing
machinery of contractile bacteriophage tails, has been
reviewed recently (Ho et al., 2014; Zoued et al., 2014). In
brief, contraction of a tail sheath-like structure made up of
TssBC propels (‘fires’) a puncturing structure made of Hcp
(TssD) and VgrG (TssI) out of the secreting cell and into a
target cell. The expelled puncturing structure consists of a
tube of stacked Hcp hexamers, topped with a VgrG trimer
‘spike’ and a final sharp ‘tip’ from a PAAR protein (Fig. 1A).
The cytoplasmic sheath is anchored in a membrane-
associated basal complex made up of a cytoplasmic
baseplate (TssAEFGK) and a membrane complex
(TssJLM). Following ‘firing’, the sheath is disassembled
by the cytoplasmic ATPase TssH (ClpV), allowing recycling
of the machinery for further rounds of secretion. As
discussed in the succeeding paragraphs, secreted proteins
are translocated into target cells by association with
components of the expelled Hcp-VgrG-PAAR structure.
Varied proteins delivered by the T6SS, known as
‘effectors’, have now been identified and shown to present
various toxic activities in target cells. Clearly, characterising
the repertoire of effectors delivered is central to under-
standing the biological role of the T6SS. Indeed the
importance of the T6SS and its distinctive roles in different
bacterial interactions (Fig. 1B and C) are becoming
increasingly appreciated. In some cases, T6SSs that target
eukaryotic cells are required for virulence in the host
organism, for example, in Vibrio cholerae and Burkholderia
species (Ma and Mekalanos, 2010; Burtnick et al., 2011;
Schwarz et al., 2014), or can mediate interactions with
eukaryotic cells (Weyrich et al., 2012; Jiang et al., 2014). In
many other cases, bacteria with so-called ‘anti-bacterial’
T6SSs should gain a fitness advantage in mixed microbial
communities, as a consequence of the injection of anti-
bacterial toxins into rival species (Hood et al., 2010;
MacIntyre et al., 2010; Murdoch et al., 2011). Anti-bacterial
T6SSs can also confer intra-species competitiveness
(Unterweger et al., 2014; Alcoforado Diniz and Coulthurst,
2015), competitive persistence in mixed-species biofilms
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cellular microbiology
(Schwarz et al., 2010) and even co-operative, self-
recognition behaviour (Wenren et al., 2013). Cells elabo-
rating an anti-bacterial T6SS adopt a self-protection system
utilising specific immunity proteins to neutralise the cognate
toxins and prevent self-intoxication or sibling-intoxication.
In this article, we review recent advances in under-
standing T6SS-delivered effector proteins, considering
both their modes of delivery and their modes of action
against prokaryotic cells, eukaryotic cells or even both.
We also briefly consider the evolution of T6SS-dependent
toxins and emphasize the contribution of their deployment
to fitness advantage in diverse microbial communities and
to successful establishment of infection in the host.
Multiple routes of effector delivery
Recent work has begun to shed light on how effectors are
recruited and delivered by the T6SS. The current model of
Fig. 1. The Type VI secretion system and its action against prokaryotic and eukaryotic target cells.
A. Schematic depiction of the T6SS firing into a target cell, with components of the expelled puncturing device highlighted in colour (green, Hcp; red,
VgrG; orange, PAAR), and effectors or effector domains shown with stars. Cargo effectors are recruited by interaction with Hcp or VgrG, whereas
specialized effectors contain effector domains fused to VgrG or PAAR.
B. General representation of an anti-bacterial T6SS, where multiple toxic effectors attack targets in the periplasm, membrane and/or cytoplasm of a
rival bacterial cell, leading to inhibition of growth or lysis.
C. Schematic illustrating how the best characterized T6SS-delivered anti-eukaryotic effectors interfere with eukaryotic host biological functions. In
epithelial cells, P. aeruginosa promotes bacterial internalization by delivering phospholipases PldA and PldB, which induce the activation of the
PI3K/Akt pathway, and VgrG2b, which binds to γ-tubulin ring complex (γTuRC). The Pld proteins bind to Akt and also their enzymatic activity
releases phosphatidic acid (PA), which is likely the signal inducing Akt phosphorylation. In phagocytic cells, V. cholerae delivers VgrG-1 from the
phagosome to the cytosol where it inhibits further phagocytosis by cross-linking actin, whereas Burkholderia utilize another specialized VgrG,
VgrG5, to induce host cell membrane fusion, promoting mononuclear giant cell formation and intercellular spread. OM, outer membrane; PG,
peptidoglycan; IM, inner membrane.
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T6SS (Fig. 1A) allows classification of effectors according
to their broad mode of delivery, into ‘cargo’ or ‘specialized’
effectors. Cargo effectors interact with components of the
expelled puncturing structure, namely, Hcp, VgrG or
PAAR, for delivery. In contrast, specialized effectors
consist of effector domains covalently fused to one of
these components, with the specialized effector typically
present as one of several homologues of that core
component (Durand et al., 2014).
Hcp appears to have a multi-faceted role in the T6SS.
Silverman and co-workers first showed that certain
effectors can interact with the interior of the hexameric
Hcp ring, allowing Hcp to direct their secretion. Further-
more, Hcp can define substrate specificity and promote the
intracellular stability of these cargo effectors (Silverman
et al., 2013; Whitney et al., 2014). It appears that Hcp
proteinsmight also be capable of functioning as specialized
effectors, because a gene encoding an Hcp-like protein
fused with an additional putative effector domain has been
identified in Salmonella enterica Arizonae (Blondel et al.,
2009). VgrG proteins are another class of structural
components able to interact with specific cargo effectors,
as shown for VgrG-1 and TseL in V. cholerae (Liang et al.,
2015; Unterweger et al., 2015), and supported by genomic
evidence that vgrG genes are often found adjacent to
putative effector genes (Barret et al., 2011; Russell et al.,
2013). Alternatively, many VgrG-based specialized effec-
tors, originally termed ‘evolved VgrGs’, have now been
described, possessing a variety of effector domains at their
C-termini (Pukatzki et al., 2007; Brooks et al., 2013). The
final class of core components that can be involved in
specific effector delivery are the recently discovered PAAR
proteins (Shneider et al., 2013). These proteins could carry
cargo effectors, although this has not yet been shown.
However, they appear to frequently act as specialized
effectors, when PAAR domains are present within larger
proteins, including Rhs proteins (Hachani et al., 2014;
Whitney et al., 2014). T6SS-associated Rhs proteins
contain PAAR domains in their N-terminal region, respon-
sible for binding to VgrG, long Rhs repeat regions and
variable C-terminal toxin (effector) domains (Koskiniemi
et al., 2013; Alcoforado Diniz and Coulthurst, 2015).
Nevertheless, it is becoming clear that delivery of
effectors can be more complex than the simple model
just described. A new class of accessory protein, which
mediates the interaction between VgrG proteins and
effectors in certain T6SSs, has been reported recently:
the ‘T6SS effector chaperones’ or ‘Type VI adaptor
proteins’, containing DUF4123 domains. These proteins
are not required for T6SS activity, but appear to interact
with their cognate effector protein and a specific VgrG to
allow delivery of the effector, exemplified by VC1417
assisting VgrG-1 dependent secretion of TseL in V.
cholerae (Liang et al., 2015; Unterweger et al., 2015).
Another member of this family, VasW, was earlier
described as playing a crucial role in the secretion of the
VasX effector (Miyata et al., 2013). Alternatively, a domain
found in the N-terminal region of a subset of T6SS
effectors, named MIX (marker for Type VI effectors), is
proposed to represent a binding region for VgrG (Salomon
et al., 2014). Another, unrelated, family of conserved
accessory proteins termed EagR (effector-associated
gene, with Rhs), formerly assigned DUF1795, has also
been reported. EagR proteins are very often encoded
upstream of rhs genes and EagR1 is specifically required
for Rhs1-dependent bacterial kill ing in Serratia
marcescens (Alcoforado Diniz and Coulthurst, 2015).
Overall, the existence of a number of basic modes of
effector recruitment, further refined using more specific
accessory proteins, likely explains how the T6SS is able to
deliver numerous and structurally diverse proteins.
Diverse and potent anti-bacterial toxins delivered by
the Type VI secretion system
It is now clear that the T6SS can deliver multiple anti-
bacterial toxins with different sites of action in a target cell
(Fig. 2). The first effectors with toxic activity against other
bacteria were identified in Pseudomonas aeruginosa and
named Tse1–3 (Hood et al., 2010). Subsequent work
revealed that Tse1 and Tse3 have bacteriolytic activity,
destroying the cell wall via peptidoglycan amidase or
muramidase activity, respectively (Russell et al., 2011).
Indeed the peptidoglycan cell wall now appears to be a
common target of T6SS effectors. Russell and co-workers
described four phylogenetically distinct families of T6SS-
delivered amidase effectors (Tae), Tae1–Tae4, starting
from a bioinformatic approach (Russell et al., 2012).
Structural and biochemical studies of the Tse1 effector,
which belongs to the Tae1 family, revealed that it displays
unrestricted access to the active site, consistent with a
broad-spectrum toxin rather than housekeeping function
(Chou et al., 2012; Ding et al., 2012). However, the
diversity within the Tae effectors may be even greater,
since two Tae4 family effectors delivered by the T6SS of
S.marcescens, Ssp1 (Tae4.1SM) and Ssp2 (Tae4.2SM),
display non-redundant substrate specificity and phenotyp-
ic consequences (English et al., 2012; Srikannathasan
et al., 2013). The cell wall-targeting effectors additionally
include three families of peptidoglycan glycoside hydro-
lase (muramidase) effectors, Tge1–3. Tge1 is exemplified
by Tse3 of P. aeruginosa whilst Tge2 of Pseudomonas
protegens has also been shown to be a T6SS-delivered
anti-bacterial effector (Russell et al., 2011; Whitney et al.,
2013). Whilst the aforementioned are all cargo effectors,
the C-terminal domain of the specialized VgrG-3 of V.
cholerae is also a peptidoglycan hydrolase (Brooks et al.,
2013).
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A group of nucleic acid-targeting cargo effectors has been
described, based on work in Agrobacterium tumefaciens.
These Tde proteins display DNase activity, dependent on a
conserved HxxD motif (Ma et al., 2014). Tse2 from P.
aeruginosa is a cytoplasmic-acting effector that acts as a
potent inhibitor of target cell proliferation and is proposed to
act as a ribonuclease (Li et al., 2012). As mentioned earlier,
Rhs proteins are polymorphic toxins and include members
that are specialized T6SS effectors. Several such Rhs
effectors have been shown to have a C-terminal toxin
domainwith anHNHendonucleasemotif andDNase activity
(Koskiniemi et al., 2013; Alcoforado Diniz and Coulthurst,
2015). The activities of the C-terminal toxin domains of
several other reported T6SS-delivered Rhs effectors are yet
to be determined. Interestingly, the toxic domain of Rhs
effectors is likely sequestered prior to secretion by a shell-
like structure formed by the Rhs repeats, similar to BC
component of insecticidal ABC toxins (Busby et al., 2013).
Type VI secretion system-delivered effectors can also
target the bacterial membrane. A diverse superfamily of
bacterial lipase/phospholipase effectors (Tle) has been
reported, sub-divided into Tle1–Tle5. The Tle1–Tle4
families exhibit the GXSXG motif, which is common in
lipases, whilst Tle5 present a dual HXKXXXXD motif
associated with phospholipase D enzymes (Russell et al.,
2013). Representatives of Tle1 and Tle2 were shown to
have phospholipase A activity and to be T6SS-dependent
anti-bacterial effectors, whilst Tle5-type effectors from P.
aeruginosa (PldAandPldB) are phospholipaseDenzymes,
which act as effectors against both bacterial and eukaryotic
cells (Dong et al., 2013b; Russell et al., 2013; Jiang et al.,
2014). Moreover, effectors predicted to have pore-forming
activity, such asVasX inV. cholerae andPA14_69520 inP.
aeruginosa, which both display similarity with pore-forming
colicins, are also important players in anti-bacterial warfare
(Miyata et al., 2013; Hachani et al., 2014).
Fig. 2. Anti-bacterial Type VI secreted effectors: cellular targets and self-protection mechanism. Schematic depiction of different classes of effector
toxins and their sites of action once delivered into a target cell. Because this is a resistant (sibling) cell, specific immunity proteins bind to their
cognate effectors in order to neutralize their activity. Dark circles with stars represent effectors, whilst lighter circles represent corresponding
immunity proteins. Examples of atomic structures of effector : immunity complexes for four classes of effector are shown in the insets (PDB entries:
Tle4PA/Tli4PA, 4R1D; VgrG3VC/TsiV3, 4NOO; Tge1PA/Tgi1PA, 4N88 and Tae4.1SM/Tai4aSM, 4BI8; Table 1). Black circles represent anti-bacterial
effectors whose function is currently unknown. OM, outer membrane; PG, peptidoglycan cell wall; IM, inner membrane.
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Notably, there are many other T6SS-dependent effec-
tors, either experimentally identified or predicted based on
genomic context, whose function is not known or readily
predictable (Barret et al., 2011; Russell et al., 2012;
Fritsch et al., 2013; Salomon et al., 2014; Unterweger
et al., 2014; Whitney et al., 2014). This implies significant
diversity of effectors and the promise of novel cellular
targets yet to be identified.
Actions of anti-eukaryotic toxins delivered by the
Type VI secretion system
Whilst T6SS-dependent virulence-related phenotypes
have been quite widely reported, only a few anti-
eukaryotic effector proteins have been identified. To date,
the well-characterized T6SS effector proteins targeting
eukaryotic cells are several specialized VgrG proteins and
cargo phospholipases (Fig. 1C). The C-terminal domain of
VgrG-1 of V. cholerae shares homology with the actin
cross-linking domain (ACD) of RtxA family toxins and
catalyses the covalent cross-linking of G-actin (monomer-
ic actin) in an ATP-dependent manner (Pukatzki et al.,
2007). Following internalization of V. cholerae cells, VgrG-
1-dependent actin cross-linking prevents host cell
cytoskeleton rearrangements, inhibiting phagocytosis
and protecting extracellular bacteria from subsequent
uptake by macrophages (Ma et al., 2009). In vitro injection
of purified VgrG1-ACD into human fibroblasts induces
actin aggregation (Pukatzki et al., 2007), whilst in vivo
actin-cross linking caused by VgrG1-ACD results in
induction of inflammatory diarrhoea that facilitates the
survival of V. cholerae in the murine intestine (Ma and
Mekalanos, 2010). The C-terminal domain of VgrG1 from
Aeromonas hydrophila also modifies host actin, present-
ing an ADP ribosyltransferase activity that induces
apoptosis via the activation of caspase 9 in HeLa cells
(Suarez et al., 2010a). VgrG2b of P. aeruginosa promotes
bacterial internalization by non-phagocytic cells through
specific binding to the γ-tubulin ring complex (Sana et al.,
2015). VgrG5 of Burkholderia pseudomallei and
Burkholderia thailandensis is required for host cell fusion,
and thus intercellular spread of bacteria. It is proposed
that the C-terminal domain may insert into host cell
membranes to mediate the fusion event (Schwarz et al.,
2014; Toesca et al., 2014).
Considering cargo effectors, recent studies have shown
that T6SS-dependent phospholipases can target eukary-
otic as well as prokaryotic cells, revealing the versatility of
such effectors across kingdoms. PldA of P. aeruginosa
degrades phosphatidylethanolamine and was first identif-
ied as an H2-T6SS-dependent Tle5 family effector
(Russell et al., 2013). A subsequent study demonstrated
that both PldA and another phospholipase D protein, PldB,
which is delivered by H3-T6SS, are able to promote
internalization in human epithelial cells via the induction of
the phophatidylinositol 3-kinase (PI3K)/Akt pathway. PldB
also acts as an anti-bacterial toxin (Jiang et al., 2014).
Similarly, TseL (Tse2VC) of V. cholerae exerts both anti-
bacterial and anti-eukaryotic activity (Dong et al., 2013b).
Addit ionally, phospholipase Pld1 in Klebsiel la
pneumoniae, encoded within a T6SS gene cluster and
thus likely a T6SS effector, was required for virulence in a
mouse pneumonia model (Lery et al., 2014).
VasX of V. cholerae, another trans-kingdom cargo
effector protein, disrupts the inner membrane of bacterial
cells and is also active against Dictyostelium discoideum
(Miyata et al., 2011; Miyata et al., 2013). EvpP, secreted
by the T6SS of Edwardsiella tarda, is required for
virulence and proliferation in fish hosts although its mode
of action is not yet known (Zheng and Leung, 2007; Wang
et al., 2009). Whilst non-specialized Hcp is not an effector,
rather a component of the secretion machinery, it is
interesting to note several studies reporting immunogenic
effects of this secreted protein. Recombinant Hcp from A.
hydrophila is reported to bind to murine macrophage-like
cells RAW 264.7 and induce or inhibit the production of
anti-inflammatory or pro-inflammatory cytokines respec-
tively (Suarez et al., 2010b). Similarly, one of two Hcp
proteins associated with a T6SS in meningitis-causing
Escherichia coli is reported to induce cytoskeleton
rearrangement, apoptosis and cytokine release in brain
endothelial cells (Zhou et al., 2012).
In general, T6SSs acting against eukaryotic cells
appear to be appropriately regulated to promote host
infections. For example, expression of the H2-T6SS of P.
aeruginosa is modulated by quorum sensing and induced
by iron limitation (Sana et al., 2012), and the activation of
T6SS-5, which delivers VgrG5, in B. pseudomallei, is
triggered by the histidine kinase VirA upon sensing the
host cytosolic glutathione, thereby facilitating bacterial
spreading at the right time, namely, when the bacteria
have escaped from the phagosome to the cytosol (Fig. 1C)
(Wong et al., 2015). Overall, recent work suggests
widespread roles for anti-eukaryotic T6SSs in host cell
interactions and virulence, and that a multitude of T6SS
dependent effectors acting against eukaryotic cells remain
to be identified.
Self-protection against anti-bacterial toxins: specific
immunity proteins
All T6SS-dependent anti-bacterial effectors identified to
date, both cargo and specialized, are encoded adjacent to
a specific immunity protein. Immunity proteins reside in
the compartment of action of the toxin (Fig. 2) and protect
the secreting cell from effectors injected by neighbouring
sibling cells or, in the case of cytoplasmic-acting effectors,
from its own effectors prior to secretion. Loss of an
1746 J. Alcoforado Diniz, Y.-C. Liu and S. J. Coulthurst
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 17, 1742–1751
immunity protein renders a bacterium susceptible to
T6SS-mediated killing or inhibition by the cognate effector.
This has provided a useful genetic means to identify T6
effectors, for example, in V. cholerae and S.marcescens
(English et al., 2012; Dong et al., 2013b).
In all cases where the mechanism of self-protection has
been examined, there is a direct interaction between the
effector and its cognate immunity protein. In other words, the
immunity protein neutralizes the effector rather than
protecting the target. A more detailed picture of how effector
toxins are inhibited by immunity proteins has been provided
by atomic structures, with associated biochemical studies, of
various effector : immunity complexes (Table 1, Fig. 2).
Together, these studies show that the immunity protein
normally binds to the toxin to block the active site, with the
exception of Tle4/Tli4 where Tli4 binding away from the
active site prevents an activating conformational change in
Tle4 (Lu et al., 2014b). The structures of the immunity
proteins and the stoichiometry of the effector : immunity
complexes vary considerably, with many of the immu-
nity proteins displaying previously undescribed protein folds.
Work inS.marcescens further revealed that two related Tae4
family effectors, Ssp1 and Ssp2, are neutralized by
structurally unrelated immunity proteins, Rap1a (Tai4aSM)
and Rap2a (Tai4SM) (Srikannathasan et al., 2013). These
two effector : immunity pairs are encoded together with two
other immunity proteins of the Tai4 family, representing
examples of ‘orphan’ immunity proteins, which do not confer
protection against endogenous effectors, but rather may
provide protection against exogenous effectors from other
organisms (English et al., 2012, Srikannathasan et al., 2013).
Evolutionary considerations
Several interesting comparisons can be made between
T6SS-delivered anti-bacterial toxins and other systems
that mediate bacterial antagonism. Specialized effectors
can be considered as examples of polymorphic toxins,
where the N-terminal domain of the protein determines
secretion or localisation (for T6SS, a core VgrG or PAAR
domain) and the final C-terminal domain is a variable toxin
domain. Furthermore, like other polymorphic toxins,
Table 1. Type VI secretion system-associated immunity proteins with reported structures, either in complex with the cognate effector or alone.
Effector/immunity Alternate name Effector activity Complex structure
Complex
stoichio-metrya Immunity onlyb Organism
Tae1PA/Tai1PA Tse1/Tsi1 Peptidoglycan
amidase
PDB 3VPJ
(Ding et al., 2012)
[PDB 4FGI, 4EQA]c
1E:1I Pseudomonas
aeruginosa
Tae3RP/Tai3 RP Peptidoglycan
amidase
PDB 4HZB
(Dong et al., 2013a)
2E:4I Ralstonia pickettii
Tae4ST/Tai4ST Peptidoglycan
amidase
PDB 4HFF
(Zhang et al., 2013)
[PDB 4J32]
2E:2I Salmonella
typhimurium
Tae4EC/Tai4EC Peptidoglycan
amidase
PDB 4HFL
(Zhang et al., 2013)
2E:2I Enterobacter
cloacae
Tae4.1SM/Tai4aSM Ssp1/Rap1a Peptidoglycan
amidase
PDB 4BI8
(Srikannathasan
et al., 2013)
2E:2I Serratia
marcescens
Tae4.2SM/Tai4.2SM Ssp2/Rap2a Peptidoglycan
amidase
PDB 3ZIB
(Srikannathasan
et al., 2013)
Serratia
marcescens
Rap1b, Rap2b d PDB 4AX2, 4B6I
(English et al., 2012)
Serratia
marcescens
Tse2/Tsi2 Unknown PDB 3RQ9
(Li et al., 2012)
Pseudomonas
aeruginosa
Tge1PA/Tgi1PA Tse3/Tsi3 Peptidoglycan
glycoside
hydrolase
PDB 4N88
(Lu et al., 2014a)
[PDB 4LUQ, 3WA5]
1E:1I Pseudomonas
aeruginosa
Tge2PP/Tgi2PP Peptidoglycan
glycoside
hydrolase
PDB 4KT3
(Whitney et al., 2013)
1E:1I Pseudomonas
protegens
VgrG3VC/TsiV3 VgrG-3/TsaB Peptidoglycan
hydrolysis
PDB 4NOO
(Yang et al., 2014)
[PDB 4NSR]
2E:2I Vibrio cholerae
Tle4PA/Tli4PA Phospholipase? PDB 4R1D
(Lu et al., 2014b)
1E:1I Pseudomonas
aeruginosa
a E:I, indicates effector: immunity stoichiometry in the complexes.
b Structures of immunity proteins where there is no effector or complex structure available.
c PDB identifiers for independent structures of the same proteins are given in square brackets.
d Rap1b and Rap2b are ‘orphan’ immunity proteins of the Tai4 class.
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specialized effectors are associated with immunity pro-
teins specific to their toxin domains and encoded immedi-
ately downstream (Zhang et al., 2012). More broadly, many
toxin domains, particularly nuclease and pore-forming
domains, appear to be shared between different antago-
nistic systems, including polymorphic contact dependent
toxins (such as Cdi and T6SS toxins) and diffusible
bacteriocins. Thus, certain T6SS-associated effectors
may have evolved from, or been a source of, toxins
associated with other systems. Another common feature of
polymorphic toxins is the presence of genes encoding
‘orphan’ C-terminal toxin domains and immunity proteins
downstream of the full length toxin-immunity locus (Poole
et al., 2011; Zhang et al., 2012). These are believed to be
remnants of past homologous recombination events, when
new toxin domains and immunity proteins have been
horizontally acquired and exchanged into the polymorphic
toxin locus. These events would allow facile acquisition and
immediate deployment of new toxins, as has been
demonstrated for Rhs in Salmonella typhimurium. Specif-
ically, extended passage yielded an evolved subpopulation
able to inhibit parental cells by deployment of an orphan
Rhs C-terminal domain, following the fusion of this domain
with the main ancestral Rhs protein through a recombina-
tion event (Koskiniemi et al., 2014).
Horizontal acquisition is also likely to be a feature of cargo
effector-immunity pairs. Considerable variation in effector-
immunity complement is observed between different strains,
and closely related effectors are frequently found in distantly
related organisms (Barret et al., 2011; Russell et al., 2012;
Russell et al., 2013; Unterweger et al., 2014). Indeed,
consistent with facile movement of effector-immunity loci
between strains and organisms, the T6SS appears to be
very effective in intra-species as well as inter-species
competition (Unterweger et al., 2014; Alcoforado Diniz and
Coulthurst, 2015). Recent work has further suggested that
specific, genetically linked accessory proteins may co-
evolve with effectors, containing conserved regions to
mediate interaction with T6SS proteins and variable regions
to interact with the cognate effector (Unterweger et al.,
2015). Additionally, a study of DNA transfer between
Bacteroidales species demonstrated for the first time the
transfer of a putative T6SS locus between strains within a
natural human ecosystem (Coyne et al., 2014).
An intriguing question is which came first, anti-bacterial
or anti-eukaryotic T6SSs? Perhaps the identification of
several effectors, including phospholipases, which are
active against both kingdoms, may help to explain the
expansion from one to the other. Was ‘cargo’ or
‘specialized’ the original mode of effector delivery?
Certainly, the frequent location of cargo genes immedi-
ately 3’ of their cognate VgrG gene is suggestive that
they once were, or in the future could be, fused into a
single specialized protein. But even highly efficient anti-
bacterial cargo effectors are not the end of the
evolutionary line. Recently, it has been shown that genes
encoding T6SS anti-bacterial effectors can be further
transferred to eukaryotic organisms to augment their
innate immune system (Chou et al., 2015). Overall, it is
tempting to speculate that acquisition of new T6SS
effector-immunity pairs may be a common way in which
new isolates of increased competitive fitness against
closely or distantly related bacteria arise. Similarly,
acquisition of new anti-eukaryotic effectors may extend
the range or efficiency of host interaction, although
whether the target specificity of effectors is the sole
factor in determining the type of cells targeted by a
particular T6SS remains to be determined.
Conclusions
The T6SS machinery delivers a diverse range of effector
proteins into both prokaryotic and eukaryotic cells. These
toxic effectors are frequently used to kill or incapacitate
surrounding bacteria in order to thrive in the polymicrobial
environment, whilst possession of cognate immunity
proteins prevents self-intoxication. Alternatively, the
T6SS can be a major direct virulence determinant,
delivering effectors that interfere with biological activities
or integrity of eukaryotic host cells during infection. It is
likely that acquisition of T6SS effectors can play an
important role in the continual evolution of bacterial
competitiveness, even transferring to eukaryotic lineages
on occasion. Looking ahead, there must surely be a great
number of T6SS-delivered effectors still to be discovered,
with the promise of new biology to be explored. Other
future areas of research include questions such as the
following: If one bacterium secretes multiple T6SS
effectors, are they all delivered simultaneously and do
they act co-ordinately in recipient cells? How do effectors
reach different compartments in target cells? What is the
role of anti-bacterial T6SSs in the healthy and diseased
microbiome and what non-antagonistic roles might their
effectors have? Long-term, we anticipate that understand-
ing how T6SS effector proteins are delivered and act in the
target cell may aid the identification of novel targets for the
development of new anti-bacterial therapies.
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